Back to search
FDAFDA · Food and drugs·Recall number D-0892-2018

ESTRADIOL 20mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-020-01

Published July 11, 2018 · Recall initiated: June 8, 2018

Summary

FDA records drug Class III recall D-0892-2018, published July 11, 2018 and initiated June 8, 2018. Recalling firm: Qualgen, LLC; Status: Terminated; Reported quantity: 2,940 pellets; Lot: lot# C211 Exp. date 10/03/2018; C257 Exp. date 12/14/2018 and lot # D001 exp. date 01/02/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Qualgen, LLC
Distributor
Nationwide in the USA
Lot
lot# C211 Exp. date 10/03/2018; C257 Exp. date 12/14/2018 and lot # D001 exp. date 01/02/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ESTRADIOL 20mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-020-01 recalled?

Yes. FDA published recall D-0892-2018 on July 11, 2018. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date.

What should I do if I have this product?

Voluntary: Firm initiated · Letter